Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis
T Hylander, L Latif, U Petersson-Westin… - Journal of allergy and …, 2013 - Elsevier
BACKGROUND: Allergen-specific immunotherapy is the only causative treatment of IgE-
mediated allergic disorders. The most common administration route is subcutaneous, which
may necessitate more than 50 allergen injections during 3 to 5 years. Recent evidence
suggests that direct intralymphatic injections could yield faster beneficial results with
considerably lower allergen doses and markedly reduced numbers of injections.
OBJECTIVE: To evaluate the effects of intralymphatic allergen-specific immunotherapy in …
mediated allergic disorders. The most common administration route is subcutaneous, which
may necessitate more than 50 allergen injections during 3 to 5 years. Recent evidence
suggests that direct intralymphatic injections could yield faster beneficial results with
considerably lower allergen doses and markedly reduced numbers of injections.
OBJECTIVE: To evaluate the effects of intralymphatic allergen-specific immunotherapy in …